Professor Carmel Hawley
Professor

Carmel Hawley

Email: 

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

721 works between 1965 and 2025
All (721) Journal Article (490) Conference Publication (225) Book Chapter (6)

301 - 320 of 721 works

2016

Journal Article

Temporal changes in deceased kidney donor characteristics in Australia

Chan, Samuel, Campbell, Scott B., Clayton, Phillip A., Mudge, David W., Cho, Yeoungjee, Hawley, Carmel M., Johnson, David W. and Francis, Ross S. (2016). Temporal changes in deceased kidney donor characteristics in Australia. Transplantation Direct, 2 (11), 1-6. doi: 10.1097/txd.0000000000000624

Temporal changes in deceased kidney donor characteristics in Australia

2016

Journal Article

Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients

Badve, Sunil V., Pascoe, Elaine M., Burke, Michael, Clayton, Philip A., Campbell, Scott B., Hawley, Carmel M., Lim, Wai H., McDonald, Stephen P., Wong, Germaine and Johnson, David W. (2016). Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients. Clinical Journal of the American Society of Nephrology, 11 (10), 1845-1855. doi: 10.2215/CJN.00190116

Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients

2016

Journal Article

Live donor study – implications of kidney donation on cardiovascular risk with a focus on lipid parameters including lipoprotein a

Doucet, Brian, Kostner, Karam, Kaiser, Omar, Hawley, Carmel and Isbel, Nicole (2016). Live donor study – implications of kidney donation on cardiovascular risk with a focus on lipid parameters including lipoprotein a. Nephrology, 21 (10), 901-904. doi: 10.1111/nep.12792

Live donor study – implications of kidney donation on cardiovascular risk with a focus on lipid parameters including lipoprotein a

2016

Journal Article

The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people With CKD: a systematic review and meta-analysis

Badve, Sunil V., Palmer, Suetonia C., Strippoli, Giovanni F. M., Roberts, Matthew A., Teixeira-Pinto, Armando, Boudville, Neil, Cass, Alan, Hawley, Carmel M., Hiremath, Swapnil S., Pascoe, Elaine M., Perkovic, Vlado, Whalley, Gillian A., Craig, Jonathan C. and Johnson, David W. (2016). The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people With CKD: a systematic review and meta-analysis. American Journal of Kidney Diseases, 68 (4), 554-563. doi: 10.1053/j.ajkd.2016.03.418

The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people With CKD: a systematic review and meta-analysis

2016

Journal Article

The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis

Quach, Kevin, Lvtvyn, Lyubov, Baigent, Colin, Bueti, Joe, Garg, Amit X., Hawley, Carmel, Haynes, Richard, Manns, Braden, Perkovic, Vlado, Rabbat, Christian G., Wald, Ron and Walsh, Michael (2016). The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis. American Journal of Kidney Diseases, 68 (4), 591-598. doi: 10.1053/j.ajkd.2016.04.011

The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis

2016

Journal Article

Predictors of transfer to home hemodialysis after peritoneal dialysis completion

Nadeau-Fredette, Annie-Claire, Hawley, Carmel, Pascoe, Elaine, Chan, Christopher T., Leblanc, Martine, Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil and Johnson, David W. (2016). Predictors of transfer to home hemodialysis after peritoneal dialysis completion. Peritoneal Dialysis International, 36 (5), 547-554. doi: 10.3747/pdi.2015.00121

Predictors of transfer to home hemodialysis after peritoneal dialysis completion

2016

Journal Article

Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials

Badve, Sunil V., Palmer, Suetonia C., Hawley, Carmel M., Pascoe, Elaine M., Strippoli, Giovanni F. M. and Johnson, David W. (2016). Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Nephrology Dialysis Transplantation, 31 (9), 1425-1436. doi: 10.1093/ndt/gfv269

Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials

2016

Journal Article

Center-specific factors associated with peritonitis risk—a multi-center registry analysis

Nadeau-Fredette, Annie-Claire, Johnson, David W., Hawley, Carmel M., Pascoe, Elaine M., Cho, Yeoungjee, Clayton, Philip A., Borlace, Monique, Badve, Sunil V., Sud, Kamal, Boudville, Neil and McDonald, Stephen P. (2016). Center-specific factors associated with peritonitis risk—a multi-center registry analysis. Peritoneal Dialysis International, 36 (5), 509-518. doi: 10.3747/pdi.2015.00146

Center-specific factors associated with peritonitis risk—a multi-center registry analysis

2016

Journal Article

Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service

Davis, Emma, Campbell, Katrina, Gobe, Glenda, Hawley, Carmel, Isbel, Nicole and Johnson, David W. (2016). Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service. BMC Nephrology, 17 (74) 74, 1-10. doi: 10.1186/s12882-016-0290-y

Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service

2016

Journal Article

Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis

Kennard, Alice, Hawley, Carmel, Tate, Jill, Klingberg, Sandra, Pretorius, Carel, Hutchison, Colin and Mollee, Peter (2016). Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis. Clinical Chemistry and Laboratory Medicine, 54 (6), 1045-1052. doi: 10.1515/cclm-2015-0799

Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis

2016

Journal Article

Long-term outcomes of end-stage kidney disease for patients with lupus nephritis

Zhang, Lei, Lee, Gavin, Liu, Xusheng, Pascoe, Elaine M., Badve, Sunil V., Boudville, Neil C., Clayton, Philip A., Hawley, Carmel M., Kanellis, John, McDonald, Stephen P., Peh, Chen Au, Polkinghorne, Kevan R. and Johnson, David W. (2016). Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney International, 89 (6), 1337-1345. doi: 10.1016/j.kint.2016.02.014

Long-term outcomes of end-stage kidney disease for patients with lupus nephritis

2016

Journal Article

Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: a multi-centre registry study

Zhang, Lei, Liu, Xusheng, Pascoe, Elaine M., Badve, Sunil V., Boudville, Neil C., Clayton, Philip A., De Zoysa, Janak, Hawley, Carmel M., Kanellis, John, McDonald, Stephen P., Peh, Chen Au, Polkinghorne, Kevan R. and Johnson, David W. (2016). Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: a multi-centre registry study. Nephrology, 21 (5), 387-396. doi: 10.1111/nep.12629

Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: a multi-centre registry study

2016

Journal Article

Intensive hemodialysis and mortality risk in Australian and New Zealand populations

Marshall, Mark R., Polkinghorne, Kevan R., Kerr, Peter G., Hawley, Carmel M., Agar, John W. M. and McDonald, Stephen P. (2016). Intensive hemodialysis and mortality risk in Australian and New Zealand populations. American Journal of Kidney Diseases, 67 (4), 617-628. doi: 10.1053/j.ajkd.2015.09.025

Intensive hemodialysis and mortality risk in Australian and New Zealand populations

2016

Journal Article

Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions

Cho, Yeoungjee, Buchel, Janine, Steppan, Sonja, Passlick-Deetjen, Jutta, Hawley, Carmel M., Dimeski, Goce, Clarke, Margaret and Johnson, David W. (2016). Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions. Peritoneal Dialysis International, 36 (2), 146-153. doi: 10.3747/pdi.2014.00291

Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions

2016

Journal Article

Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) study

Viecelli, Andrea K., Pascoe, Elaine M., Polkinghorne, Kevan R., Hawley, Carmel M., Paul-Brent, Peta-Anne, Badve, Sunil V., Cass, Alan, Johnson, David W., Kerr, Peter G., Mori, Trevor A., Scaria, Anish, Hooi, Seong L., Ong, Meng L. and Irish, Ashley B. (2016). Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) study. Nephrology, 21 (3), 217-228. doi: 10.1111/nep.12573

Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) study

2016

Journal Article

Focus on peritoneal dialysis training: working to decrease peritonitis rates

Zhang, Lei, Hawley, Carmel M. and Johnson, David W. (2016). Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrology Dialysis Transplantation, 31 (2), 214-222. doi: 10.1093/ndt/gfu403

Focus on peritoneal dialysis training: working to decrease peritonitis rates

2016

Journal Article

Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.

Krishnasamy, Rathika, Hawley, Carmel M., Stanton, Tony, Howden, Erin J., Beetham, Kassia, Strand, Haakan, Leano, Rodel L., Haluska, Brian A., Coombes, Jeff S. and Isbel, Nicole M. (2016). Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.. Nephrology, 21 (2), 108-115. doi: 10.1111/nep.12557

Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.

2016

Conference Publication

Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trial

Irish, A., Viecelli, A., Hawley, C., Hooi, L., Pascoe, E., Paul-Brent, P., Badve, S., Mori, T., Cass, A., Kerr, P., Voss, D., Ong, L. and Polkinghorne, K. (2016). Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trial. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12884

Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trial

2016

Conference Publication

Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients

Chan, S., Cho, Y., Koh, Y., Boudville, N., Mcdonald, S., Clayton, P., Pascoe, E., Francis, R., Mudge, D., Hawley, C. and Johnson, D. (2016). Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA Australia, 17–21 September 2016. Richmond, VIC Australia: Wiley-Blackwell.

Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients

2016

Conference Publication

Inflammation in Dialysis

Dheda, S., Min, H., Van, Eps C., Johnson, D., Vesey, D., Healy, H., Hawley, C. and Fahim, M. (2016). Inflammation in Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17–21 September 2016. Hoboken, NJ United States: Wiley-Blackwell. doi: 10.1111/nep.12887

Inflammation in Dialysis

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2012
    A randomised placebo-controlled trial of Oxpentifylline (Trental) in erythropoietin-resistant anaemia (ERA) in chronic kidney disease
    The Roche Foundation for Anemia Research
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au